Literature DB >> 8039919

Cellular responses to a 55-kilodalton recombinant Pneumocystis carinii antigen.

S A Theus1, D W Sullivan, P D Walzer, A G Smulian.   

Abstract

The host-parasite interaction in Pneumocystis carinii pneumonia is poorly understood. In recent years, two major groups of P. carinii antigens have been identified. One class of antigens is characterized by a broad band of immunoreactivity between 45 and 55 kDa in P. carinii derived from rats. This antigen complex is the P. carinii antigen most commonly found in respiratory tract specimens and most frequently recognized by the host immune response. The availability of a recombinant antigen has permitted studies focusing on the cellular and humoral responses to a single antigen within this class, p55. In this study, we have demonstrated that the p55 antigen elicits a cell-mediated immune response in animals previously exposed to P. carinii. Under conditions of natural exposure, the 5' portion of the molecule, p55(1-200), appears immunologically silent, failing to elicit lymphocyte proliferation or cytokine secretion. Following active immunization, the 5' portion is capable of stimulating lymphocyte proliferation. The 3' portion, p55(268-414), has at least one immunodominant region which contains a 7-amino-acid repeat motif. The cells responding to p55 include a CD4+ T cell which secretes a Th1 cytokine pattern. A detailed understanding of the host-parasite interaction will facilitate the development of immunoprophylaxis and immunotherapy for P. carinii infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8039919      PMCID: PMC302981          DOI: 10.1128/iai.62.8.3479-3484.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Multiple cross-reactivities amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria.

Authors:  R F Anders
Journal:  Parasite Immunol       Date:  1986-11       Impact factor: 2.280

2.  Human Mycobacterium tuberculosis-reactive CD4+ T-cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes.

Authors:  W H Boom; R S Wallis; K A Chervenak
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

3.  Mechanism of Pneumocystis carinii attachment to cultured rat alveolar macrophages.

Authors:  S T Pottratz; W J Martin
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

4.  Genes encoding antigenic surface glycoproteins in Pneumocystis from humans.

Authors:  S L Stringer; T Garbe; S M Sunkin; J R Stringer
Journal:  J Eukaryot Microbiol       Date:  1993 Nov-Dec       Impact factor: 3.346

5.  Proliferative and cytokine responses to a major surface glycoprotein of Pneumocystis carinii.

Authors:  S A Theus; M J Linke; R P Andrews; P D Walzer
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

6.  A 55 kDa antigen of Pneumocystis carinii: analysis of the cellular immune response and characterization of the gene.

Authors:  A G Smulian; S A Theus; N Denko; P D Walzer; J R Stringer
Journal:  Mol Microbiol       Date:  1993-03       Impact factor: 3.501

7.  T-lymphocyte responses to Pneumocystis carinii in healthy and HIV-positive individuals.

Authors:  M Forte; G Maartens; F Campbell; C Stubberfield; M Shahmanesh; D Kumararatne; H Gaston
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

8.  Alveolar macrophage release of tumor necrosis factor during murine Pneumocystis carinii pneumonia.

Authors:  J K Kolls; J M Beck; S Nelson; W R Summer; J Shellito
Journal:  Am J Respir Cell Mol Biol       Date:  1993-04       Impact factor: 6.914

9.  Host species-specific antigenic variation of a mannosylated surface glycoprotein of Pneumocystis carinii.

Authors:  F Gigliotti
Journal:  J Infect Dis       Date:  1992-02       Impact factor: 5.226

10.  Properties of the major antigens of rat and human Pneumocystis carinii.

Authors:  M J Linke; M T Cushion; P D Walzer
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

View more
  6 in total

1.  CD4+ T cell-independent vaccination against Pneumocystis carinii in mice.

Authors:  M Zheng; J E Shellito; L Marrero; Q Zhong; S Julian; P Ye; V Wallace; P Schwarzenberger; J K Kolls
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

2.  Usefulness of PCR for diagnosis of Pneumocystis carinii pneumonia in different patient groups.

Authors:  M Weig; H Klinker; B H Bögner; A Meier; U Gross
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

Review 3.  A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.

Authors:  Liang Ma; Ousmane H Cissé; Joseph A Kovacs
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

4.  Intranasal immunization confers protection against murine Pneumocystis carinii lung infection.

Authors:  J M Pascale; M M Shaw; P J Durant; A A Amador; M S Bartlett; J W Smith; R L Gregory; G L McLaughlin
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

5.  Discordant antibody and cellular responses to Pneumocystis major surface glycoprotein variants in mice.

Authors:  Lisa R Bishop; Daniel Helman; Joseph A Kovacs
Journal:  BMC Immunol       Date:  2012-07-12       Impact factor: 3.615

Review 6.  Pneumocystis Pneumonia: Immunity, Vaccines, and Treatments.

Authors:  Aaron D Gingerich; Karen A Norris; Jarrod J Mousa
Journal:  Pathogens       Date:  2021-02-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.